Science and engineering

The new Composite Lab in Isogo-ku, Yokohama, will allow automotive customers from across Asia to team up with Henkel experts to develop and test composite parts, and to establish the best process conditions to make their ideas ready for market.

India and Russia inked an inter-governmental pact for the FGFA project in 2007.

Extra calcium in the gut may lead to C. diff infections. Ironically, more calcium could be the solution, too.

Yale researchers have visualized the structure of a peculiar complex within a cell that plays a role in how the hepatitis C virus (HCV) and some cancer-causing genes initiate protein synthesis by the ribosome, the cell’s protein-making factory.

We may not be able to time a live Tyrannosaurus rex in the 100-yard dash, but scientists say they now have a good sense of the maximum speed for many of the world’s largest animals, past and present.

Raytheon Company (NYSE: RTN) delivered updates to its Advanced Weather Interactive Processing System for the current 2017 Atlantic hurricane season, providing meteorologists faster, more accurate forecasting of tropical storms and hurricanes.

Maternal obesity has been linked to a higher risk of behavioral problems in boys, according to a new study co-authored by public health professors Julianna Deardorff and Barbara Abrams.

Research links certain hormones to breast cancer cells that behave like stem cells.

Valeant Pharmaceuticals International, Inc. today announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P.

Better environmental DNA tests could help scientists save endangered species and find invasive ones.

Leidos (NYSE: LDOS), a global science and technology company, was awarded a task order from the U.S. Army to integrate, test and demonstrate the three complete Airborne Reconnaissance Low-Enhanced (ARL-E) systems under the ARL-E program of record

Roche announced today that OCREVUS® (ocrelizumab) has been approved by the Australian Therapeutic Goods Administration (TGA) for the treatment of relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS)

Amgen today announced the submission of a sNDA to the U.S. FDA and a variation to the marketing application to the EMA to include OS data from the Phase 3 head-to-head ENDEAVOR trial in the product information for KYPROLIS® (carfilzomib).

A new multimillion pound collaborative research project led by BP and The University of Manchester could help to dramatically reduce the impact corrosion has on industry worldwide.

- AGREEMENT PROMISES MAJOR LEAP FORWARD IN AUTOMATION OF DIABETES MANAGEMENT